Page 22 - Delaware Medical Journal - January/February 2020
P. 22
2019 ChristianaCare Resident and Fellow Research and Quality Improvement Symposium: Selected Research and Quality Improvement Abstracts
Selection Committee:
1 2 3 4
1. Department of Quality and Safety, ChristianaCare, 4755 Ogletown Stanton Road, Suite 2C71, Newark, DE 19718
2. The Value Institute, ChristianaCare, 4755 Ogletown Stanton Road, Suite 8E50, Newark, DE 19718 3. Department of Nursing Research, ChristianaCare, Wilmington Hospital Suite GE22, 501 W. 14th
Street, Wilmington, DE, 19801
4. Department of Academic Affairs, ChristianaCare, 4755 Ogletown Stanton Road, Ammon
Education Center Suite 2E60, Newark, DE 19718
RESEARCH ABSTRACTS
Subjective Changes in Mood and Pain After IV Ketamine for Oral and Facial Surgery
Daniel Meara, MD, DMD, MS, FACS
: Daniel Meara, MD, DMD, MS, FACS; Queen Ralph
Background: Intravenous sedation in oral and maxillofacial surgery (OMFS) promotes optimal conditions for the patient to undergo procedures and
has proven to be a safe and effective treatment adjunct in trained hands. This technique employs a variety of medications, one of the most popular and dynamic of such being Ketamine. Ketamine dissociates the thalamus
from the limbic system, causing sedation and analgesia, without respiratory depression at appropriate doses. In recent studies, Ketamine has shown an improvement in patients with chronic pain and/or depression related to its propensity to increase prefrontal glutamate transmission.
Objective(s): Today’s growing opioid epidemic and mental health awareness may allow Ketamine a secondary impact. Our objective was to determine whether subjects receiving IV Ketamine for outpatient procedures demonstrated changes in mood at follow-up, self- reported changes in chronic pain score, and decreased opioid use post-operatively.
22
Del Med J | January/February 2020 | Vol. 92 | No. 1
